Portfolio News

Tribe Technology in Co Antrim joins the London Stock Exchange with market cap of £22.2m

Tribe Tech Group listed on the London Stock Exchange on Tuesday 5th September, with a successful raise of £4.6m and an initial market capitalisation of £22.2m. Clarendon Fund Managers, Invest Northern Ireland and British Business Investments have partnered with and supported the company since December 2021 and we look forward to seeing it continue its […]

Tribe Technology in Co Antrim joins the London Stock Exchange with market cap of £22.2m Read More »

Sonrai Analytics and Cancer Research Horizons Join Forces to Drive Precision Medicine Innovation

Sonrai Analytics joins forces with Cancer Research Horizons with its AI-enabled discovery technology, Sonrai Discovery, helping to uncover the next generation of cancer biomarkers. Article taken from: https://sonraianalytics.com/sonrai-cancer-research-horizons-join-forces/ PRESS RELEASE05/09/2023 Sonrai Analytics, a Belfast-based AI data analytics company specialising in precision medicine, and Cancer Research Horizons, the innovation engine at the core of one of

Sonrai Analytics and Cancer Research Horizons Join Forces to Drive Precision Medicine Innovation Read More »

Northern Ireland software firm led by women secures £1m contract

 A female-led Belfast tech company has secured contracts valued at over £1m in the last year across the defence, healthcare, and commercial sectors. Article taken from: Belfast Telegraph Software company Kinsetsu’s client list now includes NHS hospitals in England, Wales and Scotland, the Royal Navy, Dumfries & Galloway Council, RTE and Tekno Surgical. While less

Northern Ireland software firm led by women secures £1m contract Read More »

Congratulations to portfolio company, Tribe Tech Group, that has issued its ‘Intention to Float’ documentation to the London Stock Exchange

CO Antrim manufacturer Tribe Technology has announced its intention to float on the London Stock Exchange. Article taken from: Irish News The Mallusk-based manufacturer of autonomous mining equipment confirmed on Friday morning that it will seek admission of the entire issued and to be issued share capital of the company to trading on the AIM,

Congratulations to portfolio company, Tribe Tech Group, that has issued its ‘Intention to Float’ documentation to the London Stock Exchange Read More »

Cumulus Neuroscience involved in new diagnostics assessment, Fastball EEG.

As quicker, more accurate ways to detect dementia becomes ever more urgent, Cumulus Neuroscience Ltd. has teamed up with the Universities of Bath and Bristol in the U.K. to further develop the Fastball electroencephalogram (EEG) test, a diagnostic test for earlier detection of Alzheimer’s dementia. With one in three people born in the U.K. today

Cumulus Neuroscience involved in new diagnostics assessment, Fastball EEG. Read More »

Portfolio company, SeeSense, involved in report findings deriving road safety insights.

SeeSense has partnered with Transport Accident Commission (TAC) Deakin University and iMOVE Australia to produce report findings and recommendations where their technology and data were used to understand cycling behaviour and derive road safety insights. The report states that already the data collected has provided“… a rich dataset for future research and analysis. The data is objective, and has

Portfolio company, SeeSense, involved in report findings deriving road safety insights. Read More »

A Belfast-based business behind a software platform which helps streamline the work of surveyors has been acquired by ScaleUp Capital.

Established in 2011, GoReport identified a void in the market for software which helps surveyors digitise their inspecting, reporting and analysis process. GoReport provides software which support surveys and inspections in the residential and commercial sector and is used by a range of clients to support the transition towards digital workflows, enabling surveyors to focus

A Belfast-based business behind a software platform which helps streamline the work of surveyors has been acquired by ScaleUp Capital. Read More »

Congratulations to portfolio company, PlotBox, and its senior team Sean McAllister and Leona McAllister on securing significant investment from Guinness Ventures and other existing investors.

The new investment will support PlotBox‘s strategy for global growth and expansion, enabling its continued development of best-in-class products and services that will help to revolutionise the way deathcare facilities both operate and grow. Pictured above: Leona McAllister and Sean McAllister (Joint CEO’s) PlotBox, the leading software solutions provider to cemeteries and crematoria, has announced a

Congratulations to portfolio company, PlotBox, and its senior team Sean McAllister and Leona McAllister on securing significant investment from Guinness Ventures and other existing investors. Read More »

invoX Pharma has completed a second tranche of investment into portfolio company, pHion Therapeutics, a next-generation mRNA vaccine company.

Congratulations to Helen McCarthy, Darach Neeson, and the rest of the pHion Therapeutics team, as well as Ben Toogood at invoX Pharma Limited. We look forward to continuing to support the company, along with QUBIS Ltd and other investors, on its exciting growth journey. Article taken from: https://finance.yahoo.com/ LONDON, June 01, 2023–(BUSINESS WIRE)–invoX Pharma Limited (“invoX”), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited (“Sino

invoX Pharma has completed a second tranche of investment into portfolio company, pHion Therapeutics, a next-generation mRNA vaccine company. Read More »

Congratulations to portfolio company, Cumulus Neuroscience, on completing patient enrolment.

Cumulus Neuroscience Completes Patient Enrollment for Pivotal CNS-101 Early-stage Alzheimer’s Dementia Validation Trial. Article taken from: https://cumulusneuro.com/articles/2023_05_31/ We are pleased to announce the completion of patient enrollment for our CNS-101 multi-site study. The real-world study evaluates the feasibility of using repeated sampling of validated digital measures at home in patients with early-stage Alzheimer’s disease (AD), compared with

Congratulations to portfolio company, Cumulus Neuroscience, on completing patient enrolment. Read More »